13D·WATCH Activist + Insider Intelligence Live feed Blog About Pilot
SCHEDULE Filed 2025-03-13 Event 2025-03-11 SEC 0001104659-25-023609 →

Meridian Venture Partners II GP, L.P. ANI PHARMACEUTICALS INC ANIP

Stake: 5.40% Shares: 1,184,570 CUSIP: 00182C103 Class: Common Stock, $0.0001 par value per share

Item 4 — Purpose of Transaction

The shares of Common Stock owned by the Reporting Persons were acquired solely for investment purposes.

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
1 13D/G filings on this issuer
0 other filings besides this one
Filer Track Record
1 filings by this filer
0 other filings in the data moat
Short Interest · settle 2026-03-31
DTC 12.02
3,584,301 shares short · -0.5% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers
1 holder · $9.57M
Point72 Asset Mgmt

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →